Why the study?
Does the fenoldopam prodrug SK&F R-105058 increase water and sodium excretion in anesthetized rats?
Does the fenoldopam prodrug SK&F R-105058 increase water and sodium excretion in anesthetized rats?
The fenoldopam prodrug SK&F R-105058 produces prolonged diuresis and natriuresis in rats via DA 1 receptor activation.
Answers are grounded in this paper and cite their sources.
May support DA1 prodrug development for natriuresis; hypothesis-generating in animals and requires human validation.
Recent development of and studies on fenoldopam prodrugs have shown their prolonged hemodynamic effects. This study was carried out in order to examine the effect of a fenoldopam prodrug on renal function in rats. In the present study we administered SK&F R‐105058, the 4′,7,8‐tris‐N‐ethyl carbamate ester of R‐fenoldopam, at a dose of 30 μg/kg/min intravenously to the anesthetized rats. This prodrug produced long‐lasting increases in water and sodium excretion after termination of the 30‐min drug infusion with minimum changes in hemodynamic parameters. The diuresis and natriuresis were attenuated in the presence of a selective DA 1 receptor antagonist SCH 23390. Therefore, it is suggested that production of fenoldopam from its precursor drug SK&F R‐105058 caused these prolonged renal effects, which were mediated via the activation of DA 1 receptors located on renal tubules.
No takes yet. Share an insight, caveat, or question.
Sakamoto et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: